(Q57709583)

2

0 references

P. Frewer

3

0 references

J. Alonso

4

0 references

P. B. Jones

Acta Psychiatrica Scandinavica

5

0 references

language of work or name

English

0 references

publication date

May 2003

0 references

published in

0 references

volume

107

0 references

issue

s416

0 references

page(s)

7-15

0 references

cites work

Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Recovery from psychotic illness: a 15- and 25-year international follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

A naturalistic study of risperidone maintenance treatment of outpatients with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Initiating clozapine treatment in the outpatient clinic: service utilization and cost trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Selection Bias in Clinical Trials With Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

Characteristics of outcome in schizophrenia at 13 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

Predicting the long-term outcome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

Service utilization by schizophrenic patients in Groningen and South-Verona: an event-history analysis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021

The EPSILON study of schizophrenia in five European countries. Design and methodology for standardising outcome measures and comparing patterns of care and service costs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.107.S416.4.X

7 January 2021